Category: News

  • Fighting Blood Cancer More Efficiently

    Fighting Blood Cancer More Efficiently

    On April 20, 2023, researchers from ETH Zurich and the University Hospitals of Zurich had a publi-cation released in Nature Cancer. Their work on multiple myeloma, a blood cancer, is enabled by Prof. Dr. Berend Snijder’s Pharmacoscopy technology, which was notably developed with funding by PHRT.

  • Pioneer Work in Spinal Cord Function Restoration

    Pioneer Work in Spinal Cord Function Restoration

    On May 24, 2023, Prof. Dr. Grégoire Courtine and his team of experts at EPFL have successfully published an article in Nature about their work on patients with spinal cord injuries, using a brain-spine interface to allow patients to walk again. The team of Prof. Courtine has received funding from PHRT.

  • PHRT Edu Retreat 2023

    PHRT Edu Retreat 2023

    On May 3-4, 2023, PHRT organized an Edu Retreat for the PhDs and postdocs working on PHRT projects with the goal of providing valuable input and strengthening the ties within this PHRT community. The event took place over two days in Thun and was attended by more than 35 participants.

  • Hope for patients with a severe rare disease

    Hope for patients with a severe rare disease

    New research offers potential benefits for those affected by the hereditary metabolic disease methylmalonic aciduria. By combining the results of multiple molecular analyses, scientists can better diagnose this rare and severe disease. In the future, an improved understanding of the disease might also improve treatment options.

  • Clinical Trial / Clinical Study / Human Research Call

    Clinical Trial / Clinical Study / Human Research Call

    PHRT intends to take the last step toward clinical implementation with a focused yet compelling project in human research, i.e., a clinical trial, a clinical study or a research project according to the Swiss Human Research Act (HRA). PHRT, therefore, invites successful PHRT projects to apply for a respective project.

  • SPHN and PHRT organize the 2nd Joint Personalized Health Day Switzerland, “The future of data-driven medicine in Switzerland”

    SPHN and PHRT organize the 2nd Joint Personalized Health Day Switzerland, “The future of data-driven medicine in Switzerland”

    Bern, 24 August 2022. The Swiss Personalized Health Network (SPHN), an initiative of the State Secretariat for Education, Research and Innovation, and Personalized Health & Related Tech-nologies (PHRT), a Strategic Focus Area of the ETH Domain, have organized the 2nd Joint Per-sonalized Health Day Switzerland. With more than 200 participants from research, hospitals, politics, and…

  • SPHN and PHRT support 4 “National Data Streams”

    SPHN and PHRT support 4 “National Data Streams”

    In 2021, the Swiss Personalized Health Network (SPHN) and the Personalized Health and Related Technologies (PHRT) initiative from the ETH Domain jointly launched the call for “National Data Streams” (NDS). After a two-step evaluation procedure, 4 NDS projects have been selected for funding in the fields of infectious diseases in intensive care medicine, oncology, pediatrics,…

  • Meet the Researcher: Rita Sarkis

    Meet the Researcher: Rita Sarkis

    PhD student in Bioengineering and Biotechnology, EPF Lausanne

  • Meet the Researcher: Jihyun Lee

    Meet the Researcher: Jihyun Lee

    PhD student researcher, electrical engineering and bioinformatics, ETH Zurich

  • Viviane J. Tschan receives EANM Marie-Curie Award

    Viviane J. Tschan receives EANM Marie-Curie Award

    Viviane Tschan, PhD student in the Nuclide Chemistry group at the Center for Radiopharmaceutical Sciences (PSI), received this year’s Marie Curie Award for a new concept of radioligand therapy of prostate cancer.